UNH250117C525000
- 23.30
- -1.02-4.19%
UnitedHealth Newsroom
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $697
Positive Outlook for UnitedHealth: Favorable MA Conditions and Growth Projections Drive Buy Rating
Stephens Adjusts UnitedHealth Group Price Target to $645 From $675
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $697
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
Bernstein Issues a Buy Rating on UnitedHealth (UNH)
UnitedHealth Buy Rating: Strong Growth Prospects and Value Opportunity Amid Industry Challenges
HSBC Upgrades UnitedHealth(UNH.US) to Buy Rating, Maintains Target Price $595
HSBC Upgrades UnitedHealth to Buy From Hold, Price Target Is $595
Truist Financial Maintains UnitedHealth(UNH.US) With Buy Rating, Announces Target Price $610
UnitedHealth Is Maintained at Buy by Truist Securities
UnitedHealth Group Analyst Ratings
Piper Sandler raised the Target Price for UnitedHealth to $600.
Piper Sandler Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $600
UnitedHealth Is Maintained at Overweight by Piper Sandler
UnitedHealth Group Analyst Ratings
Raymond James Maintains UnitedHealth(UNH.US) With Buy Rating
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $655
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $658